Citation Impact
Citing Papers
High Levels of Chronic Immune Activation in the T-Cell Compartments of Patients Coinfected with Hepatitis C Virus and Human Immunodeficiency Virus Type 1 and on Highly Active Antiretroviral Therapy Are Reverted by Alpha Interferon and Ribavirin Treatment
2009
Nucleic acid detection with CRISPR-Cas13a/C2c2
2017 StandoutScience
CD4+ Count–Guided Interruption of Antiretroviral Treatment
2006 Standout
Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection
2018 Standout
T Cell Responses of HIV-Infected Children after Administration of Inactivated or Live Attenuated Influenza Vaccines
2010
Autoimmune Th17 Cells Induced Synovial Stromal and Innate Lymphoid Cell Secretion of the Cytokine GM-CSF to Initiate and Augment Autoimmune Arthritis
2018 StandoutNobel
Satb1 regulates the effector program of encephalitogenic tissue Th17 cells in chronic inflammation
2019 StandoutNobel
Viral load in tissues during the early and chronic phase of non‐pathogenic SIVagm infection
2004 StandoutNobel
Efficacy and clinical effectiveness of influenza vaccines in HIV-infected individuals: a meta-analysis
2006
Thiazolidinediones
2004 Standout
Inflammation and metabolic disorders
2006 StandoutNature
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
2015 Standout
Influenza-Associated Hospitalizations in the United States
2004 Standout
Viral Load and Heterosexual Transmission of Human Immunodeficiency Virus Type 1
2000 Standout
Advances in vaccine adjuvants
1999
Pertussis immunization in HIV-1-infected infants: a model to assess the effects of repeated T cell-dependent antigen administrations on HIV-1 progression.
2000
Periluminal Distribution of HIV-Binding Target Cells and Gp340 in the Oral, Cervical and Sigmoid/Rectal Mucosae: A Mapping Study
2015 StandoutNobel
Hallmarks of aging: An expanding universe
2023 Standout
Live Attenuated versus Inactivated Influenza Vaccine in Infants and Young Children
2007 Standout
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
2006 Standout
Selenium and human health
2012 Standout
Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance
2003 Standout
Low CD4+T Cell Count Is a Risk Factor for Cardiovascular Disease Events in the HIV Outpatient Study
2010
Association between Culturable Human Immunodeficiency Virus Type 1 (HIV‐1) in Semen and HIV‐1 RNA Levels in Semen and Blood: Evidence for Compartmentalization of HIV‐1 between Semen and Blood
1998
AIDS DEMENTIA COMPLEX
1999
Role of the Microbiota in Immunity and Inflammation
2014 Standout
Treatment for Rheumatoid Arthritis and Risk of Alzheimer’s Disease: A Nested Case-Control Analysis
2016
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Randomized, double-blind, placebo-controlled trial of selenium supplements among HIV-infected pregnant women in Tanzania: effects on maternal and child outcomes
2008
Exploiting dendritic cells to improve vaccine efficacy
2002 StandoutNobel
A review of molecular recognition technologies for detection of biological threat agents
2000
The end of AIDS: HIV infection as a chronic disease
2013 Standout
Molecular Methods and Platforms for Infectious Diseases Testing
2011
Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis
2012
Secretory leukocyte protease inhibitor (SLPI) in mucosal fluids inhibits HIV‐1
1997
Outcome of Immunization of Cynomolgus Monkeys with Recombinant Semliki Forest Virus Encoding Human Immunodeficiency Virus Type 1 Envelope Protein and Challenge with a High Dose of SHIV-4 Virus
1997
Priming of Strong, Broad, and Long-Lived HIV Type 1 p55 gag -Specific CD8 + Cytotoxic T Cells after Administration of a Virus-Like Particle Vaccine in Rhesus Macaques
2000
The challenge of emerging and re-emerging infectious diseases
2004 StandoutNature
Oral manifestations associated with HIV-related disease as markers for immune suppression and AIDS
1994
Immunogenicity of a Monovalent 2009 Influenza A (H1N1) Vaccine in an Immunocompromised Population: A Prospective Study Comparing HIV-Infected Adults with HIV-Uninfected Adults
2010
Editing of a tRNA anticodon in marsupial mitochondria changes its codon recognition
1993 StandoutNobel
Periodontal diseases
2005 Standout
Trivalent Inactivated Influenza Vaccine in African Adults Infected With Human Immunodeficient Virus: Double Blind, Randomized Clinical Trial of Efficacy, Immunogenicity, and Safety
2010
Shedding of live vaccine virus, comparative safety, and influenza-specific antibody responses after administration of live attenuated and inactivated trivalent influenza vaccines to HIV-infected children
2008
Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection
2003
Humoral and Cellular Response to Influenza Vaccine in HIV-Infected Children With Full Viroimmunologic Response to Antiretroviral Therapy
2008
Changing Virus‐Host Interactions in the Course of HIV‐1 Infection
1994
The CD4 lymphocyte count and risk of clinical progression
2006
Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS
2005 StandoutNobel
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Adiponectin and Leptin Levels in HIV-Infected Subjects With Insulin Resistance and Body Fat Redistribution
2002
Mortality Associated With Influenza and Respiratory Syncytial Virus in the United States
2003 Standout
Recent advances in the discovery and delivery of vaccine adjuvants
2003
The gut microbiome as a modulator of healthy ageing
2022
Guidelines for Using Antiretroviral Agents among HIV-Infected Adults and Adolescents: The Panel on Clinical Practices for Treatment of HIV*
2002
A randomised phase IIb study of mavrilimumab, a novel GM–CSF receptor alpha monoclonal antibody, in the treatment of rheumatoid arthritis
2017
Exploiting dendritic cells to improve vaccine efficacy
2002 StandoutNobel
Functional Nucleic Acid Sensors
2009 Standout
CC CKR5: A RANTES, MIP-1α, MIP-1β Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1
1996 StandoutScience
Combination Antiretroviral Therapy and the Risk of Myocardial Infarction
2003 Standout
Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010.
2009 Standout
Exploiting dendritic cells to improve vaccine efficacy
2002 StandoutNobel
Prevention and Control of Seasonal Influenza with Vaccines
2016
Oral transmission of HIV
1998
Enhancement of Sindbis Virus Self-Replicating RNA Vaccine Potency by Linkage ofMycobacterium tuberculosisHeat Shock Protein 70 Gene to an Antigen Gene
2001 StandoutNobel
Incidence and Risk Factors for New-Onset Diabetes in HIV-Infected Patients
2008
Activation of Natural Killer T Cells by α-Galactosylceramide Rapidly Induces the Full Maturation of Dendritic Cells In Vivo and Thereby Acts as an Adjuvant for Combined CD4 and CD8 T Cell Immunity to a Coadministered Protein
2003 StandoutNobel
Complement Activation during Cardiopulmonary Bypass
1981 Standout
High Levels of Viral Replication during Primary Simian Immunodeficiency Virus SIVagm Infection Are Rapidly and Strongly Controlled in African Green Monkeys
2000 StandoutNobel
Molecular and Cellular Mechanisms of Leukocyte Chemotaxis
1981 Science
Strong serological responses and HIV RNA increase following AS 03‐adjuvanted pandemic immunization in HIV ‐infected patients
2011
Guanine nucleotides modulate the binding affinity of the oligopeptide chemoattractant receptor on human polymorphonuclear leukocytes.
1983 StandoutNobel
Coronary Heart Disease in HIV-Infected Individuals
2003
Biological activities of complement-derived peptides
1987
Inflammatory Blockade Restores Adult Hippocampal Neurogenesis
2003 StandoutScience
Mediators of Inflammation
1983
Serum Interleukin-6 (IL-6), IL-10, Tumor Necrosis Factor (TNF) Alpha, Soluble Type II TNF Receptor, and Transforming Growth Factor Beta Levels in Human Immunodeficiency Virus Type 1-Infected Individuals withMycobacterium aviumComplex Disease
2001
Immunological and Virological Analyses of Persons Infected by Human Immunodeficiency Virus Type 1 while Participating in Trials of Recombinant gp120 Subunit Vaccines
1998
Vigorous HIV-1-Specific CD4 + T Cell Responses Associated with Control of Viremia
1997 StandoutScience
Is Cytosolic Ionized Calcium Regulating Neutrophil Activation?
1983 StandoutScienceNobel
Primary Care Guidelines for the Management of Persons Infected with Human Immunodeficiency Virus: 2009 Update by the HIV Medicine Association of the Infectious Diseases Society of America
2009
Body Habitus Changes and Metabolic Alterations in Protease Inhibitor–Naive HIV-1–Infected Patients Treated With Two Nucleoside Reverse Transcriptase Inhibitors
2002
Rapid Infection of Oral Mucosal-Associated Lymphoid Tissue with Simian Immunodeficiency Virus
1999 StandoutScienceNobel
HIV Gag mRNA Transfection of Dendritic Cells (DC) Delivers Encoded Antigen to MHC Class I and II Molecules, Causes DC Maturation, and Induces a Potent Human In Vitro Primary Immune Response
2000 StandoutNobel
Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection
2015 Standout
Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS
2005 StandoutNobel
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
The Engagement of Activating FcγRs Inhibits Primate Lentivirus Replication in Human Macrophages
2006 StandoutNobel
Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) Study
2009
HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation
2004 StandoutNobel
Transfer and Evaluation of an Automated, Low-Cost Real-Time Reverse Transcription-PCR Test for Diagnosis and Monitoring of Human Immunodeficiency Virus Type 1 Infection in a West African Resource-Limited Setting
2005
Biological effects of the human complement fragments C5a and C5ades Arg on neutrophil function
1980
Transfer ribonucleic acid guanine transglycosylase isolated from rat liver
1980
Characterization of Hepatitis C Virus Core-Specific Immune Responses Primed in Rhesus Macaques by a Nonclassical ISCOM Vaccine
2001 StandoutNobel
Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
2001 Standout
Fluorescence Resonance Energy Transfer Between Quantum Dot Donors and Dye-Labeled Protein Acceptors
2003 StandoutNobel
Works of David Chernoff being referenced
Comparative Analysis of HIV-1 Viral Load Assays on Subtype Quantification: Bayer Versant HIV-1 RNA 3.0 Versus Roche Amplicor HIV-1 Monitor Version 1.5
2002
Bacillus coagulans GBI-30, 6086 Modulates Faecalibacterium prausnitzii in Older Men and Women
2015
Development of a Multi-Biomarker Disease Activity Test for Rheumatoid Arthritis
2013
Validation of a novel multibiomarker test to assess rheumatoid arthritis disease activity
2012
Relation Between HIV-1 and Hepatitis C Viral Load in Patients With Hemophilia
2001
Hepatitis C Virus Load Is Associated with Human Immunodeficiency Virus Type 1 Disease Progression in Hemophiliacs
2001
Influenza Vaccination of Human Immunodeficiency Virus (HIV)‐Infected Adults: Impact on Plasma Levels of HIV Type 1 RNA and Determinants of Antibody Response
1999
Clinical, Immunologic, and Virologic Observations Related to Human Immunodeficiency Virus (HIV) Type 1 Infection in a Volunteer in an HIV-1 Vaccine Clinical Trial
1995
Proinflammatory Cytokine and Human Immunodeficiency Virus RNA Levels during EarlyMycobacterium aviumComplex Bacteremia in Advanced AIDS
1998
Effect of prebiotics on the fecal microbiota of elderly volunteers after dietary supplementation of Bacillus coagulans GBI-30, 6086
2014
Longitudinal Analysis of Quantitative Virologic Measures in Human Immunodeficiency Virus-Infected Subjects with >=400 CD4 Lymphocytes: Implications for Applying Measurements to Individual Patients
1997
Hyperlipidemia and Insulin Resistance Are Induced by Protease Inhibitors Independent of Changes in Body Composition in Patients With HIV Infection
2000
Safety and Immunogenicity of Env 2-3, a Human Immunodeficiency Virus Type 1 Candidate Vaccine, in Combination with a Novel Adjuvant, MTP-PE/MF59
1996
Long latency event‐related potentials in patients infected with human immunodeficiency virus
1990
Elevated serum concentrations of IgE antibodies to environmental antigens in HIV-seropositive male homosexuals
1990
Immunologic and virologic evaluation after influenza vaccination of HIV-1-infected patients
1997
Natural history of HIV-associated salivary gland disease
1992
Variance of Plasma Human Immunodeficiency Virus Type 1 RNA Levels Measured by Branched DNA within and between Days
1997
Clinical And Immunologic Responses To Human Immunodeficiency Virus (HIV) Type LSF2 gp120 Subunit Vaccine Combined With MF59 Adjuvant With Or Without Muramyl Tripeptide Dipalmitoyl Phosphatidylethanolamine In Non-HIV-Infected Human Volunteers
1994
Relation Between HIV-1 and Hepatitis C Viral Load in Patients With Hemophilia
2001
Identification of the minor guanylated tRNA of rabbit reticulocytes
1976
Quantification of cytomegalovirus DNA in peripheral blood leukocytes by a branched-DNA signal amplification assay
1997
Performance characteristics for the quantitation of plasma HIV-1 RNA using branched DNA signal amplification technology.
1995
Does HIV cause salivary gland disease?
1989
Hyperlipidemia and Insulin Resistance Are Induced by Protease Inhibitors Independent of Changes in Body Composition in Patients With HIV Infection
2000
Quantification of Human Immunodeficiency Virus Type 1 RNA Levels in Plasma by Using Small-Volume-Format Branched-DNA Assays
1998
Chemotactic activity of C5ades Arg: Evidence of a requirement for an anionic peptide ‘helper factor’ and inhibition by a cationic protein in serum from patients with systemic lupus erythematosus
1980